Exelon Corporation Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Exelon Corporation Common Stock trades at $41.74 (market cap $42.99B), while Relay Therapeutics Inc. Common Stock trades at $18.14 (market cap $3.82B). The key difference: Exelon Corporation Common Stock is far larger — about 11.3× Relay Therapeutics Inc. Common Stock's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| EXC | RLAY | |
|---|---|---|
Market Cap | $42.99B | $3.82B |
Volume | 7,570,408 | 4,332,079 |
Sector | Utilities | Health |
52-Week High | $50.29 | $20.75 |
52-Week Low | $40.20 | $6.03 |
Enterprise Value | $93.85B | $2.93B |
Dividend Yield | 4.03% | — |
Typical Hold Time | — | 0 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →